- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 4, 2025 | 111.1M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 103.05M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 99.92M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 92.25M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 90.93M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $386K |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $274K |
| Capex | Q3 2025 · Sep 30, 2025 | $12.59M |
| Capex | Q3 2025 · Sep 30, 2024 | $10.13M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$65.9M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$96.22M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $25.22M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $26.86M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $30.63M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$232.21M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$283.76M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $400.99M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $406.65M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $890.09M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.01B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $479.73M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $552.51M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $657.88M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $726.99M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.30 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.57 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.10 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.09 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.30 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.57 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.10 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.09 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $29.78M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $92.81M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $33.34M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $98.49M |
| Net Income | Q3 2025 · Sep 30, 2025 | $35.09M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$45.41M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$5.33M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $3.24M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $6.5M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $14.86M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $1.57M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$1.89M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $111.87M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $337.92M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $116.52M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $345.57M |
| Revenue | Q3 2025 · Sep 30, 2025 | $149.01M |
| Revenue | Q3 2025 · Sep 30, 2025 | $448.87M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $152.63M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $444.92M |